Zenas BioPharma, Inc. (ZBIO)
38.11
+1.44
(+3.93%)
USD |
NASDAQ |
Dec 04, 16:00
38.11
0.00 (0.00%)
After-Hours: 20:00
Zenas BioPharma EPS Diluted (Quarterly): -1.222 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Royalty Pharma Plc | 0.6654 |
| Amgen, Inc. | 5.934 |
| Merck & Co., Inc. | 2.316 |
| Bristol Myers Squibb Co. | 1.079 |
| Aquestive Therapeutics, Inc. | -0.1397 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -51.50M |
| Total Expenses (Quarterly) | 51.50M |
| Enterprise Value | 1.304B |
| Earnings Yield | -11.89% |
| Normalized Earnings Yield | -11.67 |